Military and First Responders Discounts
Military and First Responders Discounts
In recent years, there has been growing interest in ketamine's potential as a treatment for chronic pain, particularly in cases where other conventional treatments have failed to provide relief.
Ketamine works on various receptors in the brain, including NMDA (N-methyl-D-aspartate) receptors, which are involved in the perception of pain. By blocking NMDA receptors and modulating other neurotransmitter systems, ketamine can disrupt the transmission of pain signals and reduce the perception of pain.
Research and clinical experience suggest that ketamine therapy may provide significant pain relief for some individuals with chronic pain including conditions such as neuropathic pain, fibromyalgia, and complex regional pain syndrome (CRPS). Ketamine's rapid onset of action and ability to target various pain pathways make it an attractive option for certain patients.
Ketamine can be administered acutely during a migraine attack to provide rapid relief of symptoms. Intravenous (IV) ketamine infusion is often used for this purpose, as it allows for quick onset of action. Ketamine's ability to modulate pain pathways and inhibit the transmission of pain signals may help alleviate migraine pain and associated symptoms.
In addition to acute treatment, ketamine therapy may also be used as a preventive measure for individuals with chronic or refractory migraines. By undergoing regular ketamine infusions, some patients may experience a reduction in the frequency, severity, and duration of migraine attacks over time. This preventive approach aims to disrupt the cycle of migraines and improve the overall quality of life for affected individuals.
Ketamine's mechanism of action in migraine treatment is not fully understood, but it is believed to involve the modulation of glutamate, an excitatory neurotransmitter involved in pain processing. Ketamine's ability to block NMDA receptors and reduce hyperexcitability in the brain may contribute to its therapeutic effects in migraines.
Ketamine therapy has emerged as a potential treatment option for individuals with post-traumatic stress disorder (PTSD), particularly in cases where other treatments have been ineffective or insufficient.
Ketamine's rapid-acting antidepressant and anxiolytic effects make it particularly promising for providing rapid relief of PTSD symptoms, such as intrusive thoughts, anxiety, and hypervigilance. Ketamine infusion therapy, administered intravenously (IV), can lead to a reduction in symptoms within hours or days after treatment.
The exact mechanisms underlying ketamine's therapeutic effects in PTSD are not fully understood, but research suggests that it may involve modulation of various neurotransmitter systems, including glutamate, gamma-aminobutyric acid (GABA), and brain-derived neurotrophic factor (BDNF). Ketamine's ability to enhance synaptic plasticity and promote neurogenesis may contribute to its antidepressant and anxiolytic effects.
One of the most remarkable aspects of ketamine therapy for TRD is its rapid onset of action. Unlike traditional antidepressants, which can take weeks or even months to exert their therapeutic effects, ketamine often produces improvement in mood within hours or days after a single infusion. This rapid response is particularly beneficial for individuals in acute distress or at risk of self-harm.
Ketamine's mechanism of action in treating depression is not fully understood, but it is believed to involve modulation of glutamate neurotransmission and activation of certain neuroplasticity pathways in the brain. By enhancing synaptic connectivity and promoting the growth of new neurons, ketamine may help restore dysfunctional neural circuits associated with depression.
While the antidepressant effects of a single ketamine infusion may be relatively short-lived, lasting days to weeks, repeated infusions over a series of treatments can lead to more sustained improvement in depressive symptoms. Some individuals may experience remission of depression or a significant reduction in symptoms that persists for weeks or months after completing a course of ketamine therapy.
Ketamine therapy is used as an adjunctive treatment alongside conventional antidepressant medications and psychotherapy for TRD. Combining ketamine with other treatment modalities is required for the overall effectiveness of depression management and to support long-term recovery.
Ketamine has been shown to modulate reward pathways in the brain, which are implicated in addiction. By targeting glutamate receptors and other neurotransmitter systems, ketamine helps reduce cravings for drugs or alcohol, making it easier for individuals to abstain from substance use.
Ketamine therapy also helps alleviate withdrawal symptoms associated with substance dependence, such as anxiety, dysphoria, insomnia, and physical discomfort. By providing rapid relief of these symptoms, ketamine facilitates the early stages of recovery and increases the likelihood of successful detoxification.
In addition to its direct effects on cravings and withdrawal symptoms, ketamine therapy offers psychological benefits for individuals with substance use disorders. Ketamine's ability to induce altered states of consciousness and promote introspection can facilitate insight, emotional processing, and motivation for change, which are important aspects of addiction recovery.
Ketamine therapy also has potential as a relapse prevention strategy for individuals in recovery from substance use disorders. By addressing underlying psychological and neurobiological factors that contribute to addiction, ketamine helps reduce the risk of relapse and supports long-term abstinence from drugs or alcohol.
Ketamine is a unique medication with several distinct properties that contribute to its diverse range of therapeutic effects and potential applications.
Ketamine's unique pharmacological properties make it a versatile medication with potential applications across a wide range of medical and psychiatric conditions. Ongoing research continues to elucidate the mechanisms of ketamine's actions and explore its therapeutic potential in diverse clinical settings.
Talk with your doctor to see if ketamine therapy is right for you.
Please reach us at hotspringsAR@9thcloud-wellness.com if you cannot find an answer to your question.
Ketamine infusion therapy involves the administration of ketamine, a dissociative anesthetic, through an intravenous (IV) infusion for the treatment of various medical and psychiatric conditions.
The effects of ketamine infusion therapy can vary depending on factors such as the dose administered, the duration of the infusion, and the individual's response to treatment. Some individuals may experience rapid relief of symptoms during or shortly after the infusion session, while others may require multiple sessions to achieve therapeutic benefits.
Ketamine infusion therapy offers a promising treatment option for individuals with various medical and psychiatric conditions, particularly those who have not responded well to other treatments.
Ketamine exerts its effects through its actions on various neurotransmitter systems in the brain, leading to a wide range of pharmacological effects.
Ketamine is a noncompetitive antagonist of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors in the brain. By blocking NMDA receptors, ketamine interferes with the transmission of excitatory signals mediated by glutamate, which plays a crucial role in synaptic plasticity, learning, memory, and mood regulation.
In addition to NMDA receptor antagonism, ketamine modulates glutamate neurotransmission through various mechanisms. Ketamine increases glutamate release in certain brain regions while simultaneously inhibiting glutamate reuptake, leading to enhanced glutamatergic signaling and synaptic transmission.
Ketamine has been shown to promote neuroplasticity, the brain's ability to adapt and reorganize in response to experience or injury. Ketamine-induced neuroplastic changes may involve increased synaptic protein expression, dendritic spine growth, and synapse formation in key brain regions implicated in mood regulation and cognition.
Ketamine alters functional connectivity patterns in the brain, leading to changes in the activity and communication between different brain regions. Ketamine-induced changes in brain network connectivity may underlie its effects on consciousness, perception, and cognition.
Ketamine affects monoaminergic neurotransmitter systems, including serotonin, dopamine, and norepinephrine, although its precise mechanisms of action on these systems are not fully understood. Ketamine's effects on monoaminergic neurotransmission may contribute to its antidepressant and psychotomimetic effects.
Emerging evidence suggests that ketamine possesses anti-inflammatory properties, which could contribute to its therapeutic effects in various conditions characterized by neuroinflammation. Ketamine's anti-inflammatory actions may involve inhibition of pro-inflammatory cytokines, modulation of immune responses, and attenuation of neuroinflammatory processes in the brain.
Ketamine's multifaceted pharmacological actions on neurotransmitter systems, synaptic plasticity mechanisms, and brain network connectivity underlie its diverse range of therapeutic effects across various medical and psychiatric conditions. Ongoing research continues to elucidate the molecular, cellular, and circuit-level mechanisms of ketamine's actions and identify new therapeutic applications for this unique medication.
In addition to the specific conditions listed at the top of this page, ketamine can be used for any condition your doctor believes can be treated with infusion therapy. Contact our office for more information.
Ketamine, like any medication, can cause side effects, although they tend to be dose-dependent and typically resolve shortly after the infusion is discontinued.
It's important to note that serious adverse reactions to ketamine infusion therapy are rare but can occur, particularly at higher doses or in individuals with certain medical conditions. We provide close monitoring by trained medical professionals during our infusions to ensure safety and minimize the risk of adverse effects. Medications are on hand to treat adverse effects.
During a ketamine infusion session, you will receive the medication through an IV drip while being monitored by healthcare providers. The experience may vary depending on the dose and duration of the infusion, but common effects include relaxation, altered perception, and dissociation. Some individuals may experience rapid relief of symptoms, while others may require multiple sessions to achieve therapeutic benefits.
The short-term effects of ketamine are relatively short due to the short half-life of the medication. However, the physical effects on the body last much longer.
A single infusion typically lasts anywhere from a few days to a month. A series of 4 – 6 infusions may last anywhere from weeks to months, and often a single booster infusion when effects are wearing off can restore and extend response. Every patient responds differently, and some patients get several months of relief with just a few infusions
Currently, none of the services provided by 9th Cloud Wellness are covered by any insurance carrier.
Ketamine infusion therapy is not typically associated with addiction when used as prescribed for medical purposes. However, ketamine has the potential for misuse and dependence at higher doses or when used recreationally. We do screen our patients for abuse and reserve the right to refuse service to anyone suspected of being under the influence of recreational drugs or alcohol.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.